Back
BioXcel Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
BTAI
BioXcel Therapeutics
Last Price:
$1.96
Seasonality Move:
3.43%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and BTAI is experiencing slight selling pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.81 | Buy |
| 20-day SMA: | 1.78 | Buy |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 7.56 | Sell |
| 8-day EMA: | 1.86 | Buy |
| 20-day EMA: | 1.89 | Buy |
| 50-day EMA: | 2.48 | Sell |
| 200-day EMA: | 13.26 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 50.53 | Buy |
| Chaikin Money Flow: | -10648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.65 - 2.07) | Buy |
| Bollinger Bands (100): | (1.84 - 5.84) | Sell |
BioXcel Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.99 while BTAI 8-day simple moving average is 1.81, which is a Buy signal.
-
The stock price of BTAI is 1.99 while BioXcel Therapeutics 20-day SMA is 1.78, which makes it a Buy.
-
BioXcel Therapeutics 50-day simple moving average is 2.13 while BTAI share price is 1.99, making it a Sell technically.
-
BTAI stock price is 1.99 and BioXcel Therapeutics 200-day simple moving average is 7.56, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
37
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.99. The Score for BTAI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
10.9M
Price in USD:
1.99
Share Volume:
95.8K
BioXcel Therapeutics 52-Week Range
52-Week High:
42.72
52-Week Low:
1.29
Sell
37
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.99 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.99 while BTAI 8-day exponential moving average is 1.86, which is a Buy signal.
-
The stock price of BTAI is 1.99 while BioXcel Therapeutics 20-day EMA is 1.89, which makes it a Buy.
-
BioXcel Therapeutics 50-day exponential moving average is 2.48 while BTAI share price is 1.99, making it a Sell technically.
-
BTAI stock price is 1.99 and BioXcel Therapeutics 200-day simple moving average is 13.26, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.06 per share, and an increase next year of $7.39 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 50.53, which suggest BioXcel Therapeutics is overbought
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.65 - 2.07), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.84 - 5.84), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.